Back to search

Article

mRNA vaccine platform demonstrates potent immunotherapeutic targeting of amyloid-β and tau pathologies in Alzheimer's disease

2025-09-16

Abstract excerpt

<title>Abstract</title> <p>Current Alzheimer’s disease (AD) immunotherapeutics face efficacy and safety limitations with antibody-based approaches. While active immunization targeting Aβ and Tau pathologies represents a promising therapeutic avenue, existing peptide/protein vaccines fail to sustain adequate antibody titers or durable immune responses. mRNA vaccines offer a promising alternative, combining sustain...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11b313e7-85e0-50bf-92b3-c7a7a39515bf
DOI
10.21203/rs.3.rs-7514957/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
mRNA vaccine platform demonstrates potent immunotherapeutic targeting of amyloid-β and tau pathologies in Alzheimer's diseaseDOI 10.21203/rs.3.rs-7514957/v1
Select a neighboring publication to make it the new centre.